Recorded Presentation from the NCCN Pharmacy Updates: Updates in the Treatment of Kidney Cancer |
1.00 |
10/03/2024 - 12:00am to 10/03/2025 - 12:00am |
NCCN Guidelines® Insights - Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024 |
1.00 |
10/10/2024 - 12:00am to 10/10/2025 - 12:00am |
NCCN Pharmacy Updates: Advances in Neoadjuvant Treatment Options in Locally Advanced and Metastatic Rectal Cancer with Deficient Mismatch Repair |
1.00 |
10/10/2024 - 12:00am to 03/09/2025 - 12:00am |
Archived NCCN Tumor Boards: Immune Checkpoint Inhibitors for First-Line Therapy in Esophagogastric/Esophagogastric Junction Cancer |
1.00 |
10/28/2024 - 12:00am to 10/28/2025 - 12:00am |
Recorded Presentation from the NCCN Pharmacy Updates: Novel Therapies for Treating ESR1 and RET-Fusion Mutations in Breast Cancer |
1.00 |
11/01/2024 - 12:00am to 11/01/2025 - 12:00am |
NCCN Guidelines® Insights - Management of Immunotherapy-Related Toxicities, Version 2.2024 |
1.00 |
11/10/2024 - 12:00am to 11/10/2025 - 12:00am |
Recorded Presentation from the NCCN Pharmacy Updates: Chemoimmunotherapy Updates in Advanced/Metastatic Non-Small Cell Lung Cancer |
1.00 |
11/12/2024 - 12:00am to 11/12/2025 - 12:00am |
Archived NCCN Tumor Boards: Multidisciplinary Management of Head and Neck Cancers |
1.00 |
11/26/2024 - 12:00am to 11/26/2025 - 12:00am |
Archived NCCN Tumor Boards: New Approaches to Treatment of Bladder Cancer |
1.00 |
11/26/2024 - 12:00am to 11/26/2025 - 12:00am |
Recorded Presentation from the NCCN Pharmacy Updates: Maintenance Strategies in the Management of Acute Myeloid Leukemia |
1.00 |
11/26/2024 - 12:00am to 11/26/2025 - 12:00am |
Amyloidosis: Diagnosis, Treatment, and Supportive Care |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Diagnosis and Management of Blastic Plasmacytoid Dendritic Cell Neoplasm |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Evaluation and Treatment of Primary Central Nervous System Lymphoma |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
Management of TP53 Mutated Mantle Cell Lymphoma |
0.50 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |